MarketInOut Stock Screener Log In | Sign Up

Regencell Bioscience Holdings Ltd

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Regencell Bioscience Holdings Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,257.96 mln
Float56.15 mln
Earnings Date10/28/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.02
Debt-free

ROE

-181
Deeply negative

ROA

-149
Deeply negative

Business Description

Regencell Bioscience Holdings Limited is a Hong Kong-based company dedicated to advancing Traditional Chinese Medicine as a modern treatment option. Founded in 2014 and based in Causeway Bay, the company applies scientific research to develop and bring to market remedies targeting brain and cognitive conditions, with a particular focus on ADHD and autism spectrum disorder.

Key Fundamentals

EPS-0.02
ROE-181
ROIC-1,240
ROA-149
EBITDA, mln-11.30
EV / EBITDA-300
EV / EBIT-289

Quote Details

Last 6.71
Change -0.15 (-2.19%)
Open 6.89
Volume 147,228
Turnover 987,900
Average Volume 419,463

Financial Ratios

Leverage Ratio1.10
Current Ratio10.77
Price / Book229
Price / Tangible Book229
Debt / Equity0.02

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio1.71
Short % of Float0.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.52% 3 / 100   
1 Month 6% 78 / 100   
2 Months 15.09% 92 / 100   
6 Months -76.96% 1 / 100   
1 Year -59.6% 4 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog